Variant mapping using mass spectrometry-based proteotyping as a diagnostic tool in von Willebrand disease.
Kreft IC, van Duijl TT, van Kwawegen C, Atiq F, Phan W, Schuller MBP, Boon-Spijker M, van der Zwaan C, Meijer AB, Hoogendijk AJ, Bierings R, Eikenboom JCJ, Leebeek FWG, van den Biggelaar M; Willebrand in the Netherlands (WiN) study group.
Kreft IC, et al.
J Thromb Haemost. 2024 Apr 27:S1538-7836(24)00231-9. doi: 10.1016/j.jtha.2024.04.011. Online ahead of print.
J Thromb Haemost. 2024.
PMID: 38679335
Free article.